If you loved our Explainer on Engineering Biology, you'll love this new summarised version. This short report takes you through the key BIA member companies working in the AMR space, and explains the cutting-edge work taking place in the UK.
Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance understanding of disease biology.
Successful applicants will be awarded a Business Voucher of up to £10,000 to support scale-up through access to IBioIC’s Bioprocess Scale-Up Facilities at FlexBIO.
Chris Molloy on what the new Government means for the sector, a farewell to Lord Patrick Vallance, gene synthesis screening and TechBio UK early bird tickets
